TY - GEN AU - Sverdlov, Oleksandr TI - Modern adaptive randomized clinical trials: statistical and practical aspects SN - 9781482239881 U1 - 615.580724 PY - 2016/// CY - Boca Raton PB - CRC Press KW - Clinical trials - Reporting KW - Clinical trials - Statistical methods KW - Drugs - Testing KW - Pharmaceutical preparations KW - Randomized controlled trials as topic KW - Biostatistics - Methods KW - Drug Evaluation - Methods N1 - Table of Contents: Preface Contributors I Introduction 1. An Overview of Adaptive Randomization Designs in Clinical Trials II Restricted Randomization 2. Efron's Biased Coin Design Revisited: Statistical Properties, Randomization-Based Inference, and Sequential Monitoring 3. Adaptive Biased Coins: Achieving Better Balance without Compromising Randomness 4. Brick Tunnel and Wide Brick Tunnel Randomization for Studies with Unequal Allocation III Covariate-Adaptive Randomization 5. Development of Novel Covariate-Adaptive Randomization Designs 6. Optimal Model-Based Covariate-Adaptive Randomization Designs 7. Statistical Inference Following Covariate-Adaptive Randomization: Recent Advances 8. Covariate-Adaptive Randomization with Unequal Allocation IV Response-Adaptive Randomization 9. Optimal Allocation Designs for a Multi-Arm Multi-Objective Clinical Trial 10. Response-Adaptive Randomization: An Overview of Designs and Asymptotic Theory 11. Statistical Inference Following Response-Adaptive Randomization 12. Sample Size Re-Estimation in Adaptively Randomized Clinical Trials with Missing Data 13. Some Caveats for Outcome Adaptive Randomization in Clinical Trials V Covariate-Adjusted Response-Adaptive Randomization 14. Efficient and Ethical Adaptive Clinical Trial Designs to Detect Treatment–Covariate Interaction 15. Longitudinal Covariate-Adjusted Response-Adaptive Randomization: Impact of Missing Data 16. Targeted Covariate-Adjusted Response-Adaptive LASSO-Based Randomized Controlled Trials 17. Covariate-Balanced Bayesian Adaptive Randomization: Achieving Tradeoff Between Inferential and Ethical Goals in Small and Moderate Size Trials VI Randomized Designs with Treatment Selection 18. Multi-Arm Multi-Stage Designs for Clinical Trials with Treatment Selection 19. Sequential Elimination in Multi-Arm Selection Trials 20. Accounting for Parameter Uncertainty in Two-Stage Designs for Phase II Dose-Response Studies VII Application and Practical Aspects 21. A Single Pivotal Adaptive Trial in Infants with Proliferating Hemangioma: Rationale, Design Challenges, Experience, and Recommendations 22. Practical Implementation of Dose–Response Adaptive Trials 23. Statistical Monitoring of Data in Response-Adaptive Randomized Clinical Trials N2 - Is adaptive randomization always better than traditional fixed-schedule randomization? Which procedures should be used and under which circumstances? What special considerations are required for adaptive randomized trials? What kind of statistical inference should be used to achieve valid and unbiased treatment comparisons following adaptive randomization designs? Modern Adaptive Randomized Clinical Trials: Statistical and Practical Aspects answers these questions and more. From novel designs to cutting-edge applications, this book presents several new and key developments in adaptive randomization. It also offers a fresh and critical look at a number of already-classical topics. Featuring contributions from statisticians, clinical trialists, and subject-matter experts in academia and the pharmaceutical industry, the text: 1. Clarifies the taxonomy of the concept of adaptive randomization 2. Discusses restricted, covariate-adaptive, response-adaptive, and covariate-adjusted response-adaptive (CARA) randomization designs, as well as randomized designs with treatment selection 3. Gives an exposition to many novel adaptive randomization techniques such as brick tunnel randomization, targeted least absolute shrinkage, and selection operator (LASSO)-based CARA randomization, multi-arm multi-stage (MAMS) designs, to name a few 4. Addresses the issues of statistical inference following covariate-adaptive and response-adaptive randomization designs 5. Describes a successful implementation of a single pivotal phase II/III adaptive trial in infants with proliferating hemangioma 6. Explores some practical aspects of phase II dose-ranging studies and examines statistical monitoring and interim analysis issues in response-adaptive randomized clinical trials (https://www.crcpress.com/Modern-Adaptive-Randomized-Clinical-Trials-Statistical-and-Practical-Aspects/Sverdlov/p/book/9781482239881) ER -